Enjoy complimentary customisation on priority with our Enterprise License!
The direct-to-consumer genetic testing market size is forecast to increase by USD 1.22 billion at a CAGR of 12.99% between 2023 and 2028. The market is experiencing significant growth, driven by the increasing adoption of these tests for early disease diagnosis and personalized healthcare. Advancements in next-generation genetic sequencing technology have made it possible for individuals to access their genetic information directly and use it in genetic testing, without the need for intermediaries. However, the market also faces challenges, including doubts over the analytical and clinical validity of DTC genetic tests. These concerns have led to regulatory scrutiny and calls for stricter diagnostic oversight to ensure the accuracy and reliability of test results. Despite these challenges, the market is expected to continue growing, driven by consumer demand for greater access to genetic information and the potential for personalized healthcare solutions.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Service
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.